Edition:
United States

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

11.31USD
15 Dec 2017
Change (% chg)

$1.05 (+10.23%)
Prev Close
$10.26
Open
$10.35
Day's High
$11.64
Day's Low
$10.35
Volume
597,922
Avg. Vol
25,990
52-wk High
$19.90
52-wk Low
$10.03

Chart for

About

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme,... (more)

Overall

Beta: --
Market Cap(Mil.): $265.39
Shares Outstanding(Mil.): 23.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

BRIEF-‍Aquinox Statement On Fda Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome​

* ‍AQUINOX STATEMENT ON FDA ADVISORY COMMITTEE MEETING TO DISCUSS INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME​

Dec 07 2017

BRIEF-Aquinox Pharmaceuticals qtrly ‍net loss per share $0.50​

* Aquinox Pharmaceuticals announces third quarter 2017 financial results

Nov 08 2017

BRIEF-Aquinox Pharmaceuticals qtrly loss per share $0.59

* Aquinox Pharmaceuticals announces second quarter 2017 financial results

Aug 08 2017

Earnings vs. Estimates